COURSE OVERVIEW
Rhinitis is the most prevalent nasal disease and is characterised by nasal mucous membrane inflammation. It can be classified into allergic & non-allergic rhinitis. Rhinitis can exert a substantial impact on the physical, social, and emotional functioning of patients. In addition, there is accumulating evidence indicating that rhinitis may interfere with work performance, since the condition is associated with sleep disturbances, daytime fatigue, and impairments in cognitive and psychomotor abilities. The goal of this activity is to educate about the impact of rhinitis on human life, the epidemiology and pathophysiology of allergic rhinitis, approaches to diagnosis, available prescription treatments and the efficacy of immunotherapy options.
LEARNING OBJECTIVES
After successfully completing this CME course, the participant should be able to:
• Enumerate the clinical spectrum of rhinitis.
• Define the clinical and economic burden of rhinitis.
• Discuss the relationship between inflammation and immunity in the upper airways.
• Identify the effects of allergic rhinitis symptoms and its treatments on the health-related quality of life (HRQOL) of patients.
• Describe key updates for the diagnosis, management and treatment of rhinitis (ARIA guidelines).
• Compare and contrast the efficacy and adverse effects associated with the various pharmacologic therapies used to manage allergic rhinitis.
• Elaborate on allergic rhinitis in pregnant women and children.